Arun Shanmugam
Research Subjects
Arun Shanmugam has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Naina Mohamed Pakkir Maideen
Dubai Academic Health Corporation, Dubai, UAE
4 shared publications- Balasubramanian Rajkapoor
Faculty of Pharmacy, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, India
3 shared publications Mirunalini Gobinath
JSS College of Pharmacy, Ooty, Tamilnadu, India
2 shared publicationsMohamed Harshath Jahir Hussain
Ratnam Institute of Pharmacy, Nellore, Andhra Pradesh, India
2 shared publicationsKaviya Ganesan
1 shared publicationKirubakaran Shanmugam
1 shared publication
Latest Publications
- Open Access
- 31 March 2025
- Published by Wolters Kluwer Health in Acupuncture and Herbal Medicine
- Vol. 5 (1) , 46-56
Review of the current clinical and preclinical evidence pertaining to the immunomodulatory effects of black seeds (Nigella sativa)
Humans and other vertebrates are safeguarded from invading pathogenic microbes by the immune system. Black seed, scientifically known as Nigella sativa, has garnered attention for its potential immunomodulatory effects in both clinical and preclinical studies. This comprehensive review aims to consolidate and analyze the existing body of evidence surrounding the immunological impact of black seeds. In this review, we analyze the immunomodulatory potentials of black seeds (N. sativa). For the purpose of finding pertinent publications, the literatures was searched in web-based databases, including Web of Science, Medline/PMC/PubMed, Embase, EBSCO, Google Scholar, Science Direct, and reference lists. Several clinical, in vivo, and in vitro studies have demonstrated that supplementation with black seeds (N. sativa) has potential immunomodulatory activity. Black seeds (N. sativa) may influence immune responses through a variety of mechanisms. By synthesizing and critically assessing the current state of knowledge on the immunomodulatory effects of black seeds, this review aims to provide valuable insights into the potential therapeutic uses and future research directions for harnessing the immunological benefits of this natural remedy.
- 31 March 2025
- Published by Wolters Kluwer Health in Acupuncture and Herbal Medicine
- Vol. 5 (1) , 46-56
Open AccessReview of the current clinical and preclinical evidence pertaining to the immunomodulatory effects of black seeds (Nigella sativa)
Humans and other vertebrates are safeguarded from invading pathogenic microbes by the immune system. Black seed, scientifically known as Nigella sativa, has garnered attention for its potential immunomodulatory effects in both clinical and preclinical studies. This comprehensive review aims to consolidate and analyze the existing body of evidence surrounding the immunological impact of black seeds. In this review, we analyze the immunomodulatory potentials of black seeds (N. sativa). For the purpose of finding pertinent publications, the literatures was searched in web-based databases, including Web of Science, Medline/PMC/PubMed, Embase, EBSCO, Google Scholar, Science Direct, and reference lists. Several clinical, in vivo, and in vitro studies have demonstrated that supplementation with black seeds (N. sativa) has potential immunomodulatory activity. Black seeds (N. sativa) may influence immune responses through a variety of mechanisms. By synthesizing and critically assessing the current state of knowledge on the immunomodulatory effects of black seeds, this review aims to provide valuable insights into the potential therapeutic uses and future research directions for harnessing the immunological benefits of this natural remedy.
- 22 January 2025
- Published by Georg Thieme Verlag KG in Drug Research
- Vol. 75 (02) , 49-59
A Review of Potentials of Carica Papaya Leaves in Dengue Viral Infection – Insights of Clinical and Preclinical Studies
One of the most widespread arboviral diseases in the world, dengue virus disease (DVD) is primarily found in tropical and subtropical regions, affecting 129 countries. The main way that the dengue virus (DENV) spreads is through the bite of a female Aedes aegypti mosquito. Symptomatic therapy and supportive care are the primary methods of managing patients with DENV infection as there is currently no approved antiviral medication for this condition. Since the guidelines from the AYUSH Ministry, Government of India, recommend 10 ml of carica papaya leaf extract (CPLE) twice daily for seven days, to treat dengue fever clinically, we plan to review the potential of carica papaya in managing DENV infection.Using terms like dengue, dengue fever, dengue hemorrhagic fever, dengue shock syndrome, and carica papaya, the literature was searched in databases like Medline/PubMed Central/PubMed, Google Scholar, Science Direct, EBSCO, Scopus, Web of Science, EMBASE, Directory of open access journals (DOAJ), and reference lists to find articles relevant to the clinical, in-vivo, in-vitro, and in-silico studies evaluating the efficacy of carica papaya in the management of dengue viral infection. This review included English-language publications that supported the use of carica papaya in the treatment of dengue fever, but it excluded publications that were duplicates.Numerous preclinical and clinical investigations, such as in-vitro, in-vivo, and in-silico studies, have identified carica papaya's anti-dengue potential. The pleiotropic effects of carica papaya, including its anti-thrombocytopenic activity, immunomodulatory effects, and larvicidal property against the Aedes aegypti mosquito species, have also been confirmed by numerous in-vitro and in-vivo studies. These effects can help patients with dengue fever by elevating their platelet count and alleviating other symptoms.To hasten recovery and reduce hospital stays, patients with DENV infection may take carica papaya leaf extract (CPLE) in addition to supportive care and symptomatic treatment. Additional randomized controlled clinical trials would be necessary to confirm the safety and effectiveness of CPLE in patients with DENV infection.
- 22 January 2025
- Published by Georg Thieme Verlag KG in Drug Research
- Vol. 75 (02) , 49-59
A Review of Potentials of Carica Papaya Leaves in Dengue Viral Infection – Insights of Clinical and Preclinical Studies
One of the most widespread arboviral diseases in the world, dengue virus disease (DVD) is primarily found in tropical and subtropical regions, affecting 129 countries. The main way that the dengue virus (DENV) spreads is through the bite of a female Aedes aegypti mosquito. Symptomatic therapy and supportive care are the primary methods of managing patients with DENV infection as there is currently no approved antiviral medication for this condition. Since the guidelines from the AYUSH Ministry, Government of India, recommend 10 ml of carica papaya leaf extract (CPLE) twice daily for seven days, to treat dengue fever clinically, we plan to review the potential of carica papaya in managing DENV infection.Using terms like dengue, dengue fever, dengue hemorrhagic fever, dengue shock syndrome, and carica papaya, the literature was searched in databases like Medline/PubMed Central/PubMed, Google Scholar, Science Direct, EBSCO, Scopus, Web of Science, EMBASE, Directory of open access journals (DOAJ), and reference lists to find articles relevant to the clinical, in-vivo, in-vitro, and in-silico studies evaluating the efficacy of carica papaya in the management of dengue viral infection. This review included English-language publications that supported the use of carica papaya in the treatment of dengue fever, but it excluded publications that were duplicates.Numerous preclinical and clinical investigations, such as in-vitro, in-vivo, and in-silico studies, have identified carica papaya's anti-dengue potential. The pleiotropic effects of carica papaya, including its anti-thrombocytopenic activity, immunomodulatory effects, and larvicidal property against the Aedes aegypti mosquito species, have also been confirmed by numerous in-vitro and in-vivo studies. These effects can help patients with dengue fever by elevating their platelet count and alleviating other symptoms.To hasten recovery and reduce hospital stays, patients with DENV infection may take carica papaya leaf extract (CPLE) in addition to supportive care and symptomatic treatment. Additional randomized controlled clinical trials would be necessary to confirm the safety and effectiveness of CPLE in patients with DENV infection.
- 1 October 2024
- Published by Bentham Science Publishers Ltd. in Current Nutrition & Food Science
- Vol. 20 (8) , 908-913
A Narrative Review on the Potential of Black Seeds (Nigella Sativa) in the Management of West Nile Virus Infection
West Nile virus (WNV) infection is a mosquito-borne illness that is endemic to Africa, Asia, the Middle East, Australia, and Europe. WNV-infected individuals can only be managed with symptomatic therapy and supportive care at this point of time. Thus, we have analyzed the possible beneficial effects of black seeds (N. sativa) in this literature review. To find relevant articles, various online databases, such as the Web of Science, Medline, PMC, PubMed, Embase, EBSCO, Google Scholar, Science Direct, and reference lists were searched. The antiviral, analgesic, anti-inflammatory, antioxidant, and immunomodulatory effects of black seeds (N. sativa) have been established by numerous clinical, animal, in vivo, in vitro, and in silico studies. It has been found that black seeds (N. sativa) have the potential to be included as adjuvant therapy in addition to symptomatic treatment and supportive care in the early stages of WNV infection once randomized controlled clinical trials (RCTs) affirm the safety and efficacy of black seeds (N. sativa) in WNV infection management as they have been considered the gold standard of treatment in clinical studies.
- 1 October 2024
- Published by Bentham Science Publishers Ltd. in Current Nutrition & Food Science
- Vol. 20 (8) , 908-913
A Narrative Review on the Potential of Black Seeds (Nigella Sativa) in the Management of West Nile Virus Infection
West Nile virus (WNV) infection is a mosquito-borne illness that is endemic to Africa, Asia, the Middle East, Australia, and Europe. WNV-infected individuals can only be managed with symptomatic therapy and supportive care at this point of time. Thus, we have analyzed the possible beneficial effects of black seeds (N. sativa) in this literature review. To find relevant articles, various online databases, such as the Web of Science, Medline, PMC, PubMed, Embase, EBSCO, Google Scholar, Science Direct, and reference lists were searched. The antiviral, analgesic, anti-inflammatory, antioxidant, and immunomodulatory effects of black seeds (N. sativa) have been established by numerous clinical, animal, in vivo, in vitro, and in silico studies. It has been found that black seeds (N. sativa) have the potential to be included as adjuvant therapy in addition to symptomatic treatment and supportive care in the early stages of WNV infection once randomized controlled clinical trials (RCTs) affirm the safety and efficacy of black seeds (N. sativa) in WNV infection management as they have been considered the gold standard of treatment in clinical studies.
- Open Access
- 30 August 2024
- Published by Georg Thieme Verlag KG in Ibnosina Journal of Medicine and Biomedical Sciences
- Vol. 16 (04) , 142-148
Pseudoephedrine-Induced Risks of Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome
Background Pseudoephedrine is a sympathomimetic drug used as a nasal/sinus decongestant in common cold remedies. Objective The purpose of this review article is to discuss the pseudoephedrine-associated posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS), which have been reported to the Medicines and Healthcare products Regulatory Agency (MHRA) of United Kingdom and Pharmacovigilance Risk Assessment Committee (PRAC) and Committee for Medicinal Products for Human Use (CHMP) of European Medicines Agency (EMA). Materials and Methods The aim is to review the literature pertinent to PRES and RCVS linked to the use of pseudoephedrine; the literature was searched in databases such as Medline/PubMed/PMC, Google Scholar, Science Direct, Ebsco, Scopus, Web of Science, Embase, and reference lists. Results The review by MHRA of the United Kingdom and PRAC and CHMP of EMA, all available evidence, including postmarketing safety data, and a few case reports, have confirmed the rare risk of PRES and RCVS associated with the use of pseudoephedrine. Conclusion Health care professionals should be aware of pseudoephedrine-associated PRES and RCVS. Patients with severe or uncontrolled hypertension or those with severe acute or chronic renal disease should avoid using products containing pseudoephedrine.
- 30 August 2024
- Published by Georg Thieme Verlag KG in Ibnosina Journal of Medicine and Biomedical Sciences
- Vol. 16 (04) , 142-148
Open AccessPseudoephedrine-Induced Risks of Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome
Background Pseudoephedrine is a sympathomimetic drug used as a nasal/sinus decongestant in common cold remedies. Objective The purpose of this review article is to discuss the pseudoephedrine-associated posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS), which have been reported to the Medicines and Healthcare products Regulatory Agency (MHRA) of United Kingdom and Pharmacovigilance Risk Assessment Committee (PRAC) and Committee for Medicinal Products for Human Use (CHMP) of European Medicines Agency (EMA). Materials and Methods The aim is to review the literature pertinent to PRES and RCVS linked to the use of pseudoephedrine; the literature was searched in databases such as Medline/PubMed/PMC, Google Scholar, Science Direct, Ebsco, Scopus, Web of Science, Embase, and reference lists. Results The review by MHRA of the United Kingdom and PRAC and CHMP of EMA, all available evidence, including postmarketing safety data, and a few case reports, have confirmed the rare risk of PRES and RCVS associated with the use of pseudoephedrine. Conclusion Health care professionals should be aware of pseudoephedrine-associated PRES and RCVS. Patients with severe or uncontrolled hypertension or those with severe acute or chronic renal disease should avoid using products containing pseudoephedrine.
- Open Access
- 1 July 2024
- Published by Oriental Scientific Publishing Company in Biosciences Biotechnology Research Asia
- Vol. 21 (2) , 501-507
The Prevalence of Psychiatric and Behavioral Comorbid Among Autistic adults
This article aims to shed light on the co-occurrence of behavioural and mental comorbidities in people with Autism. In 1943, psychiatrist Leo Kanner coined the term "Autism." Autism is a neurodevelopmental disease known as autism spectrum disorder (ASD). The three following categories are more likely to cause difficulties for adults with Autism: Social interaction, communication, and flexibility in thought and action. Autism has long-lasting effects on a person's life. People living with ASD are more likely to have one or more co-occurring mental disorders. For people with Autism, adulthood presents more difficulties. Psychiatric symptoms are more common in young people who have autism spectrum disorder (ASD) than in general people. The common mental conditions that can co-occur with ASD are ADHD, schizophrenia, depression, bipolar disorder, suicidal thoughts, and down syndrome, which are all covered in this article. This review provides a piece of in-depth knowledge about the prevalence and the co-occurrence of psychiatric and behavioural comorbidities among autistic adults.
- 1 July 2024
- Published by Oriental Scientific Publishing Company in Biosciences Biotechnology Research Asia
- Vol. 21 (2) , 501-507
Open AccessThe Prevalence of Psychiatric and Behavioral Comorbid Among Autistic adults
This article aims to shed light on the co-occurrence of behavioural and mental comorbidities in people with Autism. In 1943, psychiatrist Leo Kanner coined the term "Autism." Autism is a neurodevelopmental disease known as autism spectrum disorder (ASD). The three following categories are more likely to cause difficulties for adults with Autism: Social interaction, communication, and flexibility in thought and action. Autism has long-lasting effects on a person's life. People living with ASD are more likely to have one or more co-occurring mental disorders. For people with Autism, adulthood presents more difficulties. Psychiatric symptoms are more common in young people who have autism spectrum disorder (ASD) than in general people. The common mental conditions that can co-occur with ASD are ADHD, schizophrenia, depression, bipolar disorder, suicidal thoughts, and down syndrome, which are all covered in this article. This review provides a piece of in-depth knowledge about the prevalence and the co-occurrence of psychiatric and behavioural comorbidities among autistic adults.
- Open Access
- 3 October 2023
- Published by Green Publication
- Vol. 30 (17) , 2370-2374
COMPARATIVE STUDY OF KNOWLEDGE AND ATTITUDE TOWARDS SELECTIVE MUTISM AMONG MEDICOS AND NON-MEDICOS STUDENTS
Background: Selective Mutism (SM) is a debilitating childhood anxiety disorder, manifested by an unvarying inability of children to communicate verbally in certain social environments, despite possessing the capability to speak in others. Identifying and intervening early in Selective Mutism cases is crucial to enhance the prognosis for affected children. The significance of this study lies in its endeavor to understand the knowledge and perceptions surrounding this condition among different groups of people, primarily focusing on medical professionals and individuals without medical backgrounds. Objective: This research aims to conduct an in-depth comparative analysis to gauge the levels of awareness and understanding of Selective Mutism among individuals with medical training (medicos) and those without (non-medicos), exploring the perceptions and knowledge gaps existing in these distinct groups. Methods: A meticulous cross-sectional research study was executed employing an online survey method, spanning over a period of six months to gather diverse responses and insights related to Selective Mutism. Results: The outcomes of the study uncovered that awareness of Selective Mutism was markedly higher in medicos, with 29.5% being aware, as opposed to only 8.21% of non-medicos having knowledge of the condition. Additionally, an evident gender imbalance was noted in both groups, with a higher percentage of females demonstrating awareness of the disorder compared to their male counterparts. Conclusion: The results of this investigation underscore the prevalent dearth of knowledge and awareness regarding Selective Mutism among the broader population. This lack of understanding can propagate social stigma and act as a barrier to the early detection and treatment of this disorder. The research underscores the imperative need for extensive educational initiatives and awareness drives to foster early identification and intervention strategies for individuals grappling with Selective Mutism, thereby facilitating improved mental health outcomes.
- 3 October 2023
- Published by Green Publication
- Vol. 30 (17) , 2370-2374
Open AccessCOMPARATIVE STUDY OF KNOWLEDGE AND ATTITUDE TOWARDS SELECTIVE MUTISM AMONG MEDICOS AND NON-MEDICOS STUDENTS
Background: Selective Mutism (SM) is a debilitating childhood anxiety disorder, manifested by an unvarying inability of children to communicate verbally in certain social environments, despite possessing the capability to speak in others. Identifying and intervening early in Selective Mutism cases is crucial to enhance the prognosis for affected children. The significance of this study lies in its endeavor to understand the knowledge and perceptions surrounding this condition among different groups of people, primarily focusing on medical professionals and individuals without medical backgrounds. Objective: This research aims to conduct an in-depth comparative analysis to gauge the levels of awareness and understanding of Selective Mutism among individuals with medical training (medicos) and those without (non-medicos), exploring the perceptions and knowledge gaps existing in these distinct groups. Methods: A meticulous cross-sectional research study was executed employing an online survey method, spanning over a period of six months to gather diverse responses and insights related to Selective Mutism. Results: The outcomes of the study uncovered that awareness of Selective Mutism was markedly higher in medicos, with 29.5% being aware, as opposed to only 8.21% of non-medicos having knowledge of the condition. Additionally, an evident gender imbalance was noted in both groups, with a higher percentage of females demonstrating awareness of the disorder compared to their male counterparts. Conclusion: The results of this investigation underscore the prevalent dearth of knowledge and awareness regarding Selective Mutism among the broader population. This lack of understanding can propagate social stigma and act as a barrier to the early detection and treatment of this disorder. The research underscores the imperative need for extensive educational initiatives and awareness drives to foster early identification and intervention strategies for individuals grappling with Selective Mutism, thereby facilitating improved mental health outcomes.